Ireland· IE-PA-PA2059/008/001
Geloplasma, Solution for Infusion
A blood substitutes and plasma protein fractions product containing modified liquid gelatine + sodium chloride + magnesium chloride hexahydrate + potassium chloride, registered in Ireland by Fresenius Kabi Deutschland GmbH. The same ATC class is registered in 7 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Modified liquid gelatine + sodium chloride + magnesium chloride hexahydrate + potassium chloride is registered in 7 of 19 countries.
Countries holding a registration under ATC B05AA (blood substitutes and plasma protein fractions), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 4 of them publish a price we can compare per daily dose
Modified liquid gelatine + sodium chloride + magnesium chloride hexahydrate + potassium chloride · ATC B05AA
7 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Modified liquid gelatine + Sodium chloride + Magnesium chloride hexahydrate + Potassium chloride
- Manufacturer
- Fresenius Kabi Deutschland GmbH
- Country
- Ireland (IE)
- ATC code
- B05AA
- ATC class
- Blood substitutes and plasma protein fractions
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2059/008/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05AA
Blood substitutes and plasma protein fractions, as other registers publish it.
- PolandGeloplasmaFresenius Kabi Polska Sp. z o.o.
- IrelandGeloplasma Solution for Infusion (Polyolefine/Freeflex Bag)Fresenius Kabi Deutschland GmbH
- IrelandLG-octaplas, Powder and solvent for solution for infusionOctapharma (IP)
- IrelandLG-octaplas, solution for infusionOctapharma (IP)
- CzechiaOCTAPLAS LGOctapharma (IP) SPRL, Anderlecht
- PolandoctaplasLGOctapharma (IP) SPRL
- FinlandoctaplasLGOctapharma AB
- DenmarkOctaplasLG (0)Octapharma AB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/60c4fb3c-a1e0-4f78-81bd-0ef9e5d5bbce GET /v1/drugs/60c4fb3c-a1e0-4f78-81bd-0ef9e5d5bbce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B05AA"
],
"strength": null,
"pa_number": "PA2059/008/001",
"substances": [
"Modified liquid gelatine",
"Sodium chloride",
"Magnesium chloride hexahydrate",
"Potassium chloride",
"Sodium lactate solution"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "20/04/2007",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about modified liquid gelatine + sodium chloride + magnesium chloride hexahydrate + potassium chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.